G. Blanchet, J. Chippaux, L. Chirio, F. Ducancel, M. Goyffon et al., La fonction venimeuse, pp.275-353, 2015.

C. J. , Les serpents d'Afrique occidentale et centrale, IRD Editions, 2006.

J. Chippaux, Venins de serpent et envennimations, DIFFUSION IRD, p.288, 2002.

B. Fry, N. Vidal, J. Norman, F. Vonk, H. Scheib et al.,

K. , K. Fung, S. Hedges, M. Richardson, W. Hodgson et al.,

I. , R. Summerhayes, and E. Kochva, «Early evolution of the venom system in lizards and snakes, vol.439, pp.584-588, 2006.

N. Vidal and S. B. , HEDGES, «The molecular evolutionary tree of lizards, snakes,and amphisbaenians, Science Direct Compte Rendu Biologie, vol.332, pp.129-139, 2009.

M. Goyffon and I. Ineich, Nouveau regard sur les serpents venimeux, Medecine Tropicale, vol.68, pp.329-333, 2008.

C. Mattison, Tous les serpents du monde, DELACHAUX et NIESTLE, p.271, 2008.

P. R. , B. F. , C. G. , D. O. , V. L. et al., «The phylogeny of advanced snakes (Colubroidae), with discovery of a new subfamily and comparison of support methods for likelihood trees, Science Direct Moleculare Phylogenetics And Evolution, vol.58, pp.329-342, 2011.

V. N. , D. A. , D. P. , C. C. , C. A. et al., «The phyloleny and classification of caenophidian snakes inferred from seven nuclear protein-coding genes, Comptes Rendus Biologie, vol.330, pp.182-187, 2007.

T. R. , Database, «Higher Taxa in Extant Reptiles,» The reptile database., 8 FEVRIER 2016

R. Pyron, F. Bubrink, and J. Wiens, «A phylogeny and revised classification of Squamata, including 4161 species of lizards and snakes, BMC Evolutionary Biology, vol.13, p.93, 2013.

C. Kelly, N. Barker, M. Villet, and D. Broadley, «Phylogeny, biogeography and classification of the snake superfamily Elapoidea: a rapid radiation in the late Eocene,» Cladistic, vol.25, pp.38-63, 2009.

E. Kochva and . Serpentes, Atractaspididae) the burrowing asp; a multidisciplinary minireview, Bulletin of the Natural History Museum of London, vol.68, pp.91-99, 2002.

F. Ducancel, «Les venins des AtractaspiS, vol.68, pp.340-347, 2008.

T. Y. , S. K. , J. Tn, S. H. , F. R. et al., «Atractaspis aterrima toxins: the first insight into molecular evolution of venom in side-stabbers, » toxins, vol.11, pp.1948-1964, 2013.

H. H. and P. M. , «Identification and characterization of a taxon-specific threefinger toxin from the venom of the Green Vinesnake (Oxybelys fulgidus Colubridae), Biochimie, vol.95, pp.304-310, 2013.

M. Ivanov, J. Rage, Z. Szyndlar, and M. Venczel, «Histoire et origine géographique des faunes de serpent en Europe, vol.96, pp.15-24, 2000.

F. Ducancel and G. Blanchet, «Venins et toxines de serpents.,» chez La fonction venimeuse, pp.299-328, 2015.

W. W. , P. L. , and P. C. De, «A nesting of vipers: phylogeny and historical biogeogrphy of the Viperidae, vol.49, pp.445-459, 2008.

R. Bauchot, C. Bon, P. David, J. Gasc, and . Serpents, , 2005.

S. Weinstein, T. Smith, and K. Kardong, «Reptile venom glands form, function, and future,» chez Handbook of venoms and toxins of reptiles, MACKESSY SP, pp.76-84, 2009.

M. Sp and B. L. , «Bioweapons synthesis and storage: The venom gland of frontfanged snakes, Zoologischer Anzeiger, vol.245, pp.147-159, 2006.

R. , I. Lebrun, and D. Pimenta, «Self-proteolysis regulation in the Bothrops jararaca venom: the metallopeptidases and their intrinsic peptidic inhibitor, Comparative Biochemistry Physiology Part C: Toxicology & Pharmacology, vol.147, pp.424-433, 2008.

B. Young, K. Zahn, M. Blair, and J. Lalor, «Functional subdivision of the venom gland musculature and the regulation of venom expulsion in rattlesnakes, Journal of Morpholy, vol.246, pp.249-259, 2000.

I. K. Bryan-g and . Fry,

H. W. Casewell, «(Chap1) Seeing the Woods for the Trees: Understanding Venom Evolution as a guide for Biodiscovery,» chez Venoms to

, Royal society of chemistry / Gleenn F. King, pp.1-36, 2015.

U. D. Liège, «Venins, Poisons et Toxines,» 28 JANVIER 2016

J. Almeida, L. Rescende, A. Silva, R. Ribeiro, A. Soares et al.,

C. , S. Marangoni, S. Da, and . Silva, «Biochemical and functional studies of ColTx-I, a new myotoxic phospholipase A2 isolated from Crotalus oreganus lutosus (Great Basin rattlesnake) snake venom, Toxicon, vol.117, pp.1-12, 2016.

A. M. ,

. , Edailson A. Corrêa, «Isolation, structural and functional characterization of a new Lys49 phospholipase A2 homologue from Bothrops neuwiedi urutu with bactericidal potential, » Toxicon, vol.115, pp.13-21, 2016.

R. R. and -. ,. , Vanessa Danielle Menjon Muller, «Crotoxin and phospholipases A 2 from Crotalus durissus terri fi cus showed antiviral activity against dengue and yellow fever viruses, Toxicon, vol.59, pp.507-515, 2012.

, «Antitumoral Potential of Tunisian Snake Venoms Secreted Phospholipases A2,» BioMed Research International, p. (9pages), 2013.

T. S. Ryan-j and . Mccleary, Reptile Venoms as a Platform for Drug Development,» chez Venoms to Drugs, Venom as a Source for the Development of human Therapeutics, vol.5

G. F. King, , pp.129-162, 2015.

B. , Cousin X, «Acetylcholinesterase from snake venom as a model for its nerve and muscle counterpart, J Nat Toxines, vol.8, pp.285-294, 1999.

B. E. Dhananjaya, «Snake Venom Nucleases,Nucleotidases, and Phosphomonoesterases,» Handbook of venins et toxines de reptiles, pp.155-172, 2009.

D. C. Dhananjaya and B. L. , «An overview on nucleases (DNase, RNase, and phosphodiesterase) in snake venoms, Biochimie (Mosc), vol.75, issue.%11, pp.1-6, 2010.
DOI : 10.1134/s0006297910010013

S. M. Tassia and . Costa, «Snake venom L-amino acid oxidases: an overview on their antitumor effects, Journal of Venomous Animals et les toxines , y compris les maladies tropicales, vol.20, p.123, 2014.

C. B. Élida-cleyse-gomes-da-mata, J Venom Anim Toxins Incl Trop Dis, vol.23, p.13, 2017.

Z. Abdelkafi-koubaa, M. Morjen, N. Srairi-abid, M. E. Ayeb, N. Marrakchi et al., , pp.1-01, 2014.

. , Guo C, «Past decade study of snake venom L-amino acid oxidase, Toxicon, pp.302-311, 2012.

G. K. Kemparaju and K. , «Snake venom hyaluronidase: a therapeutic target, Cell Biochem Funct, vol.24, issue.%11, pp.7-12, 2006.
DOI : 10.1002/cbf.1261

R. R. , B. J. , -. M. Castanheira, and L. E. , Journal of Venomous Animals and Toxins including Tropical Diseases, vol.20, p.125, 2014.

S. Sm, «The long road of research on snake venom serine proteinases, Toxicon, vol.62, pp.19-26, 2013.

F. Y. Matsui and T. , «Snake venom proteases affecting hemostasis and thrombosis, Biochim Biophys Acta, vol.1477, pp.146-156, 2000.
DOI : 10.1016/s0167-4838(99)00268-x

C. Renard, «THESE: L'action des venins ophidien sur l'hémostase

, Lorraine / université henri poincare, 2006.

I. Limam, M. El-ayeb, and N. Marrakchi, «Les métalloprotéases des venins de serpents : structure,biosynthèse et fonction(s).,» Archive de l'Institut, 2010.

R. M. Kini and C. Y. Koh, «Metalloproteases Affecting Blood Coagulation,Fibrinolysis and Platelet Aggregation from Snake Venoms: Definition and Nomenclature of Interaction Sites.,» Toxins, vol.284, pp.1-27, 2016.
DOI : 10.3390/toxins8100284

URL : https://www.mdpi.com/2072-6651/8/10/284/pdf

F. O. , .. Y. , and .. A. , Mion, «Action des venins sur la coagulation sanguine : diagnostic des syndromes hémorragiques, Bull Soc Pathol Exot, vol.95, pp.132-138, 2002.

A. Galat, G. Gross, P. Drevet, A. Sato, and A. Menez, «Conserved structural determinants in three-fingered protein domains, The FEBS Journal, vol.275, pp.3207-3225, 2008.

G. Gross and P. Drevet, «Les toxines à trois doigts : même structure, même mécanisme de repliement ?,» chez Rencontres en Toxinologie, SFET Société Francaise pour l'Etude des Toxines, 2008.

K. R. and D. R. , «Structure, function and evolution of tree-finger toxins: mini proteins with multiple targets, Toxicon, vol.6, pp.855-867, 2010.

G. M. Larréché, «Neurotoxines ophidiennes/ Neurotoxine from snake venom,» Annales Françaises d'Anestésie et de Réanimation, vol.27, pp.310-316, 2008.

A. M. Servent, «Snake Neurotoxins that Interact with Nicotinic Acetylcholine Receptors.,» Handbook of Neurotoxicology, vol.1, pp.385-425, 2002.

, Institut des sciences biologiques CNRS (Centre National de la Rcherche Scientifique)/, fev 2016, CNRS, «Des benzodiazépines dans les venins de serpent !

, Pierre Rosso, «MmTX1 and MmTX2 from coral snake venom potently modulate GABAA receptor activity

, Proc Natl Acad Sci US A. (PNAS), vol.12, pp.891-900

G. Mion and S. Larréché, «Conférence: Syndrome cobraïque,» Médecine Tropical, vol.68, pp.348-358, 2008.

H. S. and .. P. , Sampaio SC, «Crotoxin: novel activities for a classic beta-neurotoxin, Toxicon, vol.55, pp.1045-1060, 2010.

R. B. Harvey and A. L. , «Dendrotoxins: Structure-Activity Relationships and Effects on Potassium Ion Channels, vol.11, pp.3065-3072, 2004.

E. Karisson and P. Mimi, RODRIGUEZ-ITHURRALDE, «Fasciculins, anticholinesterase toxins from the venom of the green mamba Dendroapsis angusticeps, Journal de physiologie, vol.79, pp.232-240, 1984.

R. K. Sardar and . Gasanov, «Snake Venom Cytotoxins, Phospholipase A2s, and Zn2+-dependent Metalloproteinases: Mechanisms of Action and Pharmacological Relevance, J Clin Toxicol, vol.4, p.11, 2014.

S. Lee, C. Lin, C. Wang, P. Wu, H. Huang et al., «Endocytotic Routes of Cobra Cardiotoxins Depend on Spatial Distribution of Positively Charged and Hydrophobic Domains to Target Distinct Types of Sulfated Glycoconjugates on Cell Surface, The Journal of biological chemistry, vol.289, pp.20170-20181, 2014.

N. Oguiura, M. Boni-mitake, and G. Radis-baptista, Toxicon, vol.46, pp.363-370, 2005.

V. Fadel, P. Bettendorff, T. Herrmann, X. J. De-azervedo, E. Oliveira et al., «Automated NMR structure determination and disulfide bond identification of the myotoxin crotamine from Crotalus durissus terrificus, Toxicon, vol.46, pp.759-767, 2005.

F. L. , Nicastro G, «Solution structure of crotamine, a Na+ channel affecting toxin from Crotalus durissus terrificus venom, Eur J Biochem, vol.270, pp.1969-1979, 2003.

, Irina Kerkis, «State of the Art in the Studies on Crotamine, a Cell Penetrating Peptide from South American Rattlesnake,» BioMed Research International, 2014.

C. E. , Toyama MH, «Biochemical characterization of two crotamine isoforms isolated by a single step RP-HPLC from Crotalus durissus terrificus (South American rattlesnake) venom and their action on insulin secretion by pancreatic islets, Biochim Biophys Acta, vol.1474, issue.%11, pp.56-60, 2000.

K. I. , Radis-Baptista G, «Crotamine, a small basic polypeptide myotoxin from rattlesnake venom with cell-penetrating properties, Curr Pharm Des, vol.17, pp.4351-4361, 2011.

K. ,. and .. V. , Kerkis A 1, «Crotamine is a novel cell-penetrating protein from the venom of rattlesnake Crotalus durissus terrificus, FASEB J, vol.18, pp.1407-1409, 2004.

D. and G. M. Atractaspis, Medecine tropicale, vol.68, pp.340-347, 2008.

D. W. Jr, S. H. , M. P. , T. A. , and L. M. , «Calciceptine, a peptide isolated from black mamba venom, is a specific blocker of the L-type calcium channel, Proceedings of the National Academy of Sciences of the United States of America, vol.6, pp.2437-2440, 1991.

R. Kini, R. A. Caldwell, Q. Y. Wu, and H. J. Evans, «Flanking Proline Residues Identify the L-Type Ca2+ Channel Binding Site of Calciseptine and FS2+, Biochemistry, vol.37, pp.9058-9063, 1998.

J. L. Kallech-ziri, «Les désintégrines issues des venins de serpents: Classification et potentiel thérapeutique, vol.84, pp.29-37, 2007.

M. Fs, «Snake venoms and the hemostatic system, Toxicon, vol.36, pp.1749-1800, 1998.

J. C. Maria-konstantakaki, «Docking of ?-cobratoxin suggests a basal conformation of the nicotinic receptor, Biochemical and Biophysical Research Communications, vol.359, pp.413-418, 2007.

H. J. , Li, «Preparation, characterization and nasal delivery of ?cobrotoxin-loaded poly(lactide-co-glycolide)/polyanhydride microspheres

, Control. Release, vol.108, pp.10-20, 2005.

, «Venoms-Based Drug Discovery: Proteomic and Transcriptomic Approaches,» chez Venoms to drugs/ Venoms as a Source for the Development of Human Therapeutics, pp.80-96, 2015.

Y. Banerjee, J. Mizuguchi, R. Iwanaga, and S. Kini, «Hemextin AB Complex, a Unique Anticoagulant Protein Complex from Hemachatus haemachatus (African Ringhals Cobra) Venom That Inhibits Clot Initiation and Factor VIIa Activity, The Journal of Biological Chemistry, vol.280, pp.42601-42611, 2005.

M. A. , Erika dos Santos Nunes, «Purification of a lectin with antibacterial activity from Bothrops leucurus snake venom, Comparative Biochemistry and Physiology Partie B: Biochimie et Biologie Moléculaire, vol.159, issue.%11, pp.57-63, 2011.

J. L. Sarray and «. Serpents, » Archives. Institu. Pasteur Tunis, vol.82, pp.69-80, 2008.

M. A. Sampaio, «Snake venom galactoside-binding lectins: a structural and functional overview, » J Venom Anim Toxins Incl Trop Dis, vol.21, p.115, 2015.

M. , «Structures and functions of snake venom CLPs (C-type lectin-like proteins) with anticoagulant-, procoagulant-, and platelet-modulating activities, Toxicon, vol.45, pp.1099-1114, 2005.

J. E. Arlinghaus and F. T. , «C-type lectin-like proteins from snake venoms, Toxicon, vol.60, pp.512-519, 2012.
DOI : 10.1016/j.toxicon.2012.03.001

L. Q. , Clemetson KJ, «Snake C-type lectin-like proteins and platelet receptors, Pathophysiol Haemost Thromb, vol.34, pp.150-155, 2005.

L. Aloe and G. N. Chaldakov, «The Multiple Life of Nerve Growth Factor: Tribute to Rita Levi-Montalcini, vol.30, pp.4-7, 1909.

L. G. Sh-farsky, «Bothrops asper snake venom and its metalloproteinase BaP-1 activate the complement system, » Médiateurs inflamm, vol.9, pp.213-221, 2000.

, (chap3) Venoms-Based Drug Discovery: Proteomic and Transcriptomic Approaches,» chez Venoms to Drugs/ Venom as a Source for the Development of Human Therapeutique, pp.80-96, 2015.

J. Largillet, «Sophia : les venins historiques de Pasteur dans la collection de VenomeTech, vol.8

J. Echterbille, ?. «les-venins-d'animaux-nouvelle-panacée, and ». Athena-le-mag-scientifique, , pp.13-15, 2013.

L. Quinton and T. Polytechnique, Caractérisation de toxines peptidiques par spectrométrie de masse à haute résolution, 2006.

R. Lebrun, . «la-spectrométrie-de, and . Masse, une technique d'étude structurale des protéines.,» FR3479 CNRS-AMU Plate-forme Protéomique de l'Institut de Microbiologie de la Méditerranée cours 2013

V. Hibou and M. De-masse-en-tandem, , pp.2-04

, affsaps, «Le séquencage à haut débit, méthodes et enjeux en medecine

W. C. Vetter, «(chap 4) Venoms-Based Drug Discovery: Bioassays, Electrophysiology, High-Throughput Screens and Target Identification,» chez Venoms to Drugs/ Venom as a Source for the Development of Human Tgerapeutics, pp.97-128, 2015.

L. S. Liu-b, «Technological advances in high-throughput screening, Am J Pharmacogenomics, vol.4, pp.263-276, 2004.

E. , «Méthodes d'études in silico, » chez Reproduction et environnement, pp.187-191, 2011.

K. Mezhoud,

M. Limdstrom, «Protéines :Modélisation, Prédiction, Conception, 2007.

C. Koh and R. Kini, «From snake venom toxins to therapeutics-Cardiovascular examples, » Toxicon, vol.59, pp.497-506, 2012.

F. Navarro, Les toxines d'origine animale posssédant des propriétés analgésiques : mode d'action et application médicale humaine, 2012.

J. Chippaux, «Venins animaux dans la recherche biologique.,» Ethnologie française, vol.34, p.192, 2004.

A. A. ,

, Rajendra W, «Toxins in anti-nociception and anti-inflammation

W. Rajendra, A. Armugam, K. Jeyaseelan, and . Toxicon, , vol.44, pp.1-17, 2004.

D. S. Ashis and K. Mukherjee, «Medical and diagnostic application of snake venom proteomes, Journal of proteins and proteomics, vol.2, issue.%11, pp.31-40, 2011.

R. Joseph, S. Pahari, W. C. Hodgson, and R. Kini, «Hypotensive Agents from Snake Venoms,» Current Drug Targets-Cardiovascular & Hematological Disorders, vol.4, pp.437-459, 2004.

C. Y. Koh and R. Kini, «From snake venom toxins to therapeutics-Cardiovascular examples, » Toxicon, vol.59, pp.497-506, 2011.

P. May, «CAPTOPRIL (the treatment for high blood pressure derived from snake venom

N. Tourneur and . «du-venin-de-vipère-au-captopril,

N. Veran, «. Pediatrique, F. Thèse, and . De-pharmacie, , pp.8-17, 2009.

S. H. Ferreira, «A bradykinin-potentiating factor (BPF) present in the venom of bothrops jararaca, British Journal of Pharmacology Chemother, vol.24, issue.%11, pp.163-169, 1965.

D. W. Ondetti, «History of the Design of Captopril and Related Inhibitors of Angiotensin Converting Enzyme, » Hypertension, vol.17, pp.589-592, 1991.

E. G. Erdös, «The ACE and I: how ACE inhibitors came to be, » Le FASEB Journal, vol.20, pp.1034-1038, 2006.

F. D.-m.-d.-c.-l'avc,

J. A. and .. A. , Vink S, «Natriuretic peptide drug leads from snake venom, Toxicon, vol.59, pp.434-445, 2012.

B. K. , Ondrej Lisy, «Design, Synthesis, and Actions of a Novel Chimeric Natriuretic Peptide: CD-NP, J Am Coll Cardiol, vol.52, issue.%11, pp.60-68, 2008.

A. «peptides-natriurétiques, C. Bnp, and . Pharmacorama, Connaissance des médicaments

K. R. ,

G. Singh, «Novel snake venom ligand dendroaspis natriuretic peptide is selective for natriuretic peptide receptor-A in human heart: downregulation of natriuretic peptide receptor-A in heart failure, Circ Res, vol.99, pp.183-190, 2006.

T. G. Lueder, S. J. Sangaralingham, B. H. Wang, D. A. Andrew, R. Kompa et al., «Renin-Angiotensin Blockade Combined With Natriuretic Peptide System Augmentation: Novel Therapeutic Concepts to Combat Heart Failure, Circ Coeur Fail, vol.6, pp.594-605, 2013.

C. H. , Lee CY, «Pharmacodynamics of a novel designer natriuretic peptide, CD-NP, in a first-in-human clinical trial in healthy subjects, J Clin Pharmacol, vol.49, pp.668-673, 2009.

L. H. Lee and C. Y. «designer-natriurétique-peptides, J Investig Med, vol.57, issue.%11, pp.18-21, 2009.

J. Neutel, W. Rolston, S. Maddock, S. Goldsmith, M. Koren et al., Lieu, «Initial experience with subcutaneous infusion of Centeretide in patients with chronic heart failure, Journal of the American College of Cardiology, vol.59, p.113, 2012.

, Sébastien Dutertre, «Venoms-Based Drug Discovery: Proteomic and Transcriptomic Approaches,» chez Venoms to Drugs/ Venom as a Source for the Development of Human Therapeutique, pp.80-96, 2015.

I. Y. Watanabe and T. X. , «Smooth muscle relaxing and hypotensive activities of synthetic calciseptine and the homologous snake venom peptide FS2, Jpn J Pharmacol, vol.68, issue.3, pp.305-313, 1995.

O. R. ,

N. Teramoto, «Effects of calciseptine on unitary barium channel currents in guinea-pig portal vein, Pflugers Arc, vol.432, pp.462-470, 1996.

R. M. Kini, «Molecular moulds with multiple missions : functional sites in tree-finger toxins, Clinical and Experimental Pharmacology and Physiology, vol.29, pp.815-822, 2002.

R. M. Kini, «Proline brackets and identification of potential functional sites in proteins: Toxins to therapeutics, Toxicon, vol.36, issue.%111, pp.1659-1670, 1998.

S. C. Das and B. , «Pretreatment with sarafotoxin 6c prior to coronary occlusion protects against infarction and arrhythmias via cardiomyocyte mitochondrial K(ATP) channel activation in the intact rabbit heart during ischemia/reperfusion, Cardiovasc Drugs Ther, vol.21, pp.243-251, 2007.

T. Sajevic and A. , Leonardi et I. Kri?aj, «Haemostatically active proteins in snake venoms, » Toxicon, vol.57, pp.6627-645, 2011.

C. J. ,

Q. Lu, J Thromb Haemost, vol.3, pp.1791-1799, 2005.

G. S. , «Therapeutic alternatives from venoms and toxins, Indian Journal of Pharmacology, vol.39, pp.260-264, 2007.

J. Chippaux, ». Du-diagnostic, . La-recherche, and . Des-sciences, , p.50, 2007.

A. M. Perchuc and M. Wilmer, «Diagnostic Use of Snake Venom Components in the Coagulation Laboratory,» chez Toxins and Hemostasis, pp.747-766, 2010.

S. P. Gawade, Indian J Pharmacol, vol.39, pp.259-264, 2007.

K. J. Clemetson, «Snalec (Snake C-Type Lectins) that activate platelet,» Toxin and hemostasis, pp.621-636, 2010.

S. Sarray, J. Luis, M. Elayeb, and N. Marrakchi, «Snake venom C-type lectins and their receptor on platelets an cancerous cells,» Archive de l'institut Pasteur de Tunis, vol.85, pp.69-80, 2008.

N. A. Marsh, «Procoagulant Proteins and Diagnostic Agents/ Diagnostic Uses of Snake Venom,» Haemostasis, vol.31, pp.211-221, 2001.

A. R. , B. M. , and W. L. , «Snake venom probes of platelet adhesion receptors and their ligands, Toxicon, vol.45, pp.1051-1061

M. A. Sampaio, «Snake venom galactoside-binding lectins: a structural and functional overview, » J Venom Anim Toxins Incl Trop Dis, vol.21, p.115, 2015.

D. B. Bhattacharjee, «Therapeutic Use of Snake Venom Components: A Voyage from Ancient to Modern India, » Mini-Reviews in Organic Chemistry, vol.11, issue.%11, pp.45-54, 2014.

K. J. , Segers, «Structural models of the snake venom factor V activators from Daboia russelli and Daboia lebetina, Proteins, vol.64, pp.968-984, 2006.

G. , Nicolaes et R. Jan, «Activation of factor V by venom proteases, » Toxin reviews, vol.25, pp.217-234, 2008.

G. J. and .. T. , Rosing J, «Factor V activation and inactivation by venom proteases, Haemostasis, vol.31, pp.241-246, 2001.

D. B. Bhattacharjee, «Therapeutic Use of Snake Venom Components: A Voyage from Ancient to Modern India, » Mini-Reviews in Organic Chemistry, vol.11, issue.%11, pp.45-54, 2014.

«. Cryopep, . Pict®, and . Cryopep,

P. D. and .. W. , Calatzis A, «Prothrombinase-induced clotting time assay for determination of the anticoagulant effects of unfractionated and lowmolecular-weight heparins, fondaparinux, and thrombin inhibitors, Am J Clin Pathol, vol.130, pp.44-454, 2008.

D. A. Hoppensteadt, J. Cunanan, J. M. Walenga, and J. Fareed, «Development of Prothrombinase Induced Cloting Time (Pefakit, PiCT) Assay and it Validation in the Monitoring of Anti-Xa and Anti-FIIa Drugs, Blood, vol.104, p.1858, 2005.

P. M. Wilmer, C. Stocker, B. Bühler, M. B. Conell, and M. A. Calatzis, «A Novel Prothrombin-Based APC-R / Improved Distinction of Factor V Wild-Type and Factor V Leiden Using a Novel Prothrombin-Based Activated Protein C Resistance Assay, Am J Pahol, pp.836-842, 2004.

. D. Gmbh and . «acticlot-protein-c-resistance,

. Pentapharm, A. De-pefakit®, and ». ,

H. S. , -. .. Quehenberger, and P. , «Evaluation of a highly specific functional test for the detection of factor V Leiden, Int. J. Clin. Lab. Res, vol.30, pp.113-117, 2000.

G. Freyburger and S. Labrouche, «Facteur V Leiden (VL) et Résistance à la Protéine C activée (PCA), Facteur II Leiden (G20210 G>A), aspects physiopathologiques et stratégies diagnostiques.,» SPECTRA BIOLOGIE, n° %1162, pp.60-74, 2007.

T. G. and R. J. Venom, Activators of Factor X: An Overview, Haemostasis : Procoagulant Proteins and Diagnostic Agents, vol.31, pp.225-233, 2001.

R. J. Tans and G. , «Snake venom activators of factor X: an overview, » Hémostase, vol.31, pp.225-233, 2001.

S. Takeda, «Structural Aspects of the Factor X Activator RVV-X from Russell's Viper Venom,» Toxins and Hemostasis, pp.465-484, 2010.

S. Bnl, X. «rvv-factor, and B. Stago,

. Fr&dl=fr&lp=en_fr&a=http%3a%2f%2fcatalog, stagobnl.com%2fen%2fproduct%2fhemostasis%2fsnake_venoms_inhibitors%2f338%2f rvv_factor_x

R. M. Hardisty and R. A. Hutton, «Platelet Aggregation and the Availability of Platelet Factor 3.,» bjh, vol.12, pp.764-776, 1966.

, «Diagnostic des anticoagulants circulants de type lupique,» John Libbey, (hématologie), vol.2, p.13, 1996.

, a. professionnels, «Biologie des anomalies de l'hémostase, Tome VI : détection d'un anticoagulants de type lupique, 2011.

G. W. Moore, A. P. Culhane, J. C. Maloney, and B. J. Hunt, «Taipan snake venom time coupled with ecarin time enhances lupus anticoagulant detection in nonanticoagulated patients, Blood Coagulation and Fibrinolysis, vol.27, p.14, 2015.

. Stago,

«. Stago and . Stago, Inc. Introduces STA® Staclot® DRVV Lupus Anticoagulant Assays

M. S. , Quehenberger P, «The Factor V (Leiden) test: evaluation of an assay based on dilute Russell Viper Venom Time for the detection of the Factor V Leiden mutation, Thrombosis Research, vol.96, pp.125-133, 1999.

T. J. Ivey and L. M. , «Determination of activated protein C resistance in anticoagulated and lupus positive patients, Blood Coagul Fibrinolysis, vol.11, pp.439-445, 2000.

H. A. Solano and C. , «The use of two different APC resistance assay systems provides optimal sensitivity and specificity for diagnosing genetic APC resistance, Blood Coagul. Fibrinolysis, vol.8, pp.268-273, 1997.

E. Oger, C. Leroyer, B. Mercier, and D. Mottier, «Assessment of activated protein C resistance using a new and rapid venom-based test : STAT Staclot APC-R,» Blood coagulation and fibrinolysis, vol.9, pp.355-359, 1998.

D. Herak, M. Milos, and R. Zadro, «Improvement of STA : STACLOT APC-R Test for the Detection of Facteur V Leiden by Using APCR ration, Thrombosis and Haemostasis, vol.3, p.11, 2005.

T. , Rosing J, «Structural and functional properties of snake venom prothrombin activators, Toxicon, vol.30, pp.1515-1527, 1992.

S. Sanjay and M. K. , «The catalytic subunit of pseutarin C, a group C prothrombin activator from the venom of Pseudonaja textilis, is structurally similar to mammalian blood coagulation factor Xa, Thrombosis and haemostasis, vol.92, pp.509-521, 2004.

«. Pentapharm,

, Practical-Haemostasis.com, «Ecarin Clotting Time,» A Practical Guide to Laboratory Haemostasis, 2013.

J. Chippaux, Venins de serpent et envennimations, DUNKERQUE: DIFFUSION IRD, p.288, 2002.
DOI : 10.4000/books.irdeditions.10612

G. Nowak, «The ecarin clotting time, a universal method to quantify direct thrombin inhibitors, Pathophysiol Haemost Thromb, vol.33, pp.173-183, 2003.

E. D. Devignes, «Utilisation du temps de coagulation par l'écarine en sang total pour la surveillance d'un traitement anticoagulant par lépirudine (Refludan®) au cours de circulation extracorporelle dans un contexte de thrombopénie induite par l'héparine, Ann Biol Clin, vol.63, pp.201-208, 2005.

I. G. and -. S. Kher, «Surveillance du traitement par les inhibiteurs directs de la thrombine : temps de céphaline avec activateur ou temps d'écarine, John Libbey, vol.58, pp.275-279, 2000.

A. Angelillo-scherrer, «Les anticoagulants oraux directs dans la pratique médicale: implications pour le laboratoire de l'hémostase.,» pipette-Swiss laboratory

. Medicine, , 2014.

O. A. Lange and U. , «Ecarin chromogenic assay: an innovative test for quantitative determination of direct thrombin inhibitors in plasma, Hamostaseologie, vol.25, pp.293-300, 2005.

». Ecarin and . Pratique-haemostasis, com / Guide pratique de l'hémostase en laboratoire, 2013.

D. A. Triplett, K. F. Stocker, G. A. Unger, and L. K. Barna, «The Textarin/Ecarin Ratio: a confirmatory test for lupus anticoagulants,» Thrombosis and haemostasis, vol.70, pp.925-931, 1993.

J. Francis, «A new chromogenic assay for the specific determination of prothrombin, Journal of Clinical Pathology, vol.32, pp.651-654, 19979.

V. Rao and R. Kini, «Pseutarin C, a prothrombin activator from Pseudonaja textilis venom: Its structural and functional similarity to mammalian coagulation factor XaVa complex, Thrombosis and Haemostasis, vol.88, pp.611-619, 2002.

P. P. Stephen and T. H. Earl, «Drug development from Australian elapid snake venoms and the Venomics pipeline of candidates for haemostasis: Textilinin-1 (Q8008), Haempatch (TM) (Q8009) and CoVase (TM) (V0801), vol.59, pp.456-463, 2012.

, UnitProt, «UnitProtKB-Q7SZN0 (FA5V_PSETE) Venom prothrombin activator pseutarin-C non catalytic subunit

, Uniprot, «UniProtKB-Q56VR3 (FAXC_PSETE) Venom prothrombine activator pseutarin-C catalytic subunit, 2017.

M. S. ,

R. L. Warner, «Hemostatic properties of a venomic protein in rat organ trauma, Exp Mol Pathol. 2009 décembre, vol.87, issue.3, pp.204-211, 2009.

K. R. Ashok and K. Shenoy, «Effects of botropase on clotting factors in healthy human volunteers, vol.5, pp.71-74, 2014.

S. Fati, «Contribution à l'étude ethnotoxicologique d'un gecko communément appelé salamandre : le genre Hemidactylus. Légende mythe ou réalité ?

. Médecine, de-Portail malien d'information de santé, vol.29, 2005.

;. Doctissimo and . Doctissimo, «REPTILASE 1 UK/mL Solution injectable et pour application locale Boîte de 10 Ampoules de 1 mL, vol.22, p.9, 2016.

T. De-reptilase, Unversité libre de bruxelles

B. Boutière-albanèse, ». De-reptilase, and . Em-consulte, , 2007.

, «Fiche Analyse: Temps de Reptilase

M. ,. Henrik and K. Kjaergard, «Vivostat system autologous fibrin sealant: preliminary study in elective coronary bypass grafting,» The Annals of Thoracic Surgery, vol.66, pp.482-486, 1998.

A. Barna, E. Charpentier, B. Fahlgren, V. Looten, and P. L. Guillevin, «Avis du CEDIT : Intérêt de l'hémostatique chirurgical autologue Vivostat®, 2014.

A. Barna, E. Charpentier, B. Fahlgren, V. Looten, and L. Guillevin,

A. Paris and C. Du, , 2014.

». «vivostat-_colle-de-fibrine-autologue and P. Cedit-assistance-hopitaux-publique-de,

«. Vivostat® and . Vivostat®,

M. Williams, «Snake venom helps hydrogels stop the bleeding, 2015.

, 6/snake-venom-helps-hydrogels-stop-the-bleeding/&prev=search

T. S. , Zulys VJ, «Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass, Anesthesiology, vol.71, pp.870-877, 1989.

M. U. , -. ,. Robin, and R. Kanagasabaya, «Cardiopulmonary bypass with danaparoid sodium and ancrod in heparin-induced thrombocytopenia,» The Annals of Thoracic Surgery, vol.66, pp.567-569, 1998.

A. R. ,

D. G. Sherman, «Intravenous ancrod for treatment of acute ischemic stroke: the STAT study: a randomized controlled trial. Stroke Treatment with Ancrod Trial, JAMA, vol.283, pp.2395-2403, 2000.

M. D. , Samsa GP, «Cost-effectiveness of ancrod treatment of acute ischaemic stroke: results from the Stroke Treatment with Ancrod Trial (STAT), J Eval Clin Pract, vol.8, issue.%11, pp.61-70, 2002.

K. R. Hennerici-mg-et-l.-e-;-»-lancette, d'ESTAT, «Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial, vol.368, pp.1871-1878, 2006.

. , Markland FS, «Kallikrein-like activity of crotalase, a snake venom enzyme that clots fibrinogen, Proc Natl Acad Sci U S A, vol.79, pp.1688-1692, 1982.

T. I. and .. P. , Henschen-Edman AH, «Crotalase, a fibrinogen-clotting snake venom enzyme: primary structure and evidence for a fibrinogen recognition exosite different from thrombin, Thromb Haemost, vol.81, issue.%11, pp.81-86, 1999.

K. E. and .. S. , Niewiarowski S, «Thrombocytin, a serine protease from Bothrops atrox venom. 2. Interaction with platelets and plasma-clotting factors, Biochimie, vol.18, pp.3570-3577, 1979.

N. S. , Kirby EP, «Thrombocytin, a serine protease from Bothrops atrox venom.1. Purification and characterization of the enzyme, Biochimie, vol.18, pp.3564-3570, 1979.

P. Kubisz, A. Arabi, F. Seghier, and S. Cronberg, Thrombosis Research, vol.33, pp.225-227, 1984.

G. E. , B. H. , and S. K. , «Endothelium-dependent relaxant effect of thrombocytin, a serine proteinase from Bothrops atrox snake venom, on isolated pig coronary arteries, Toxicon, vol.29, pp.725-732, 1991.

B. Lc, S. Am, C. Fl, R. Vm, F. Al et al., RS, «Biochemical and biological evaluation of gyroxin isolated from Crotalus durissus terrificus venom, Journal of Venomous Animals et les toxines , y compris les maladies tropicales, vol.17, p.11, 2011.

O. K. , Alves da Silva JA, «Gyroxin increases blood-brain barrier permeability to Evans blue dye in mice, Toxicon, vol.57, issue.%11, pp.162-167, 2011.

S. P. Da-silva and J. A. , «Gyroxin and its biological activity: effects on CNS basement membranes and endothelium and protease-activated receptors, Curr Med Chem, vol.19, pp.281-291, 2012.

K. M. and .. L. , Yonamine CM, «Enzyme specificity and effects of gyroxin, a serine protease from the venom of the South American rattlesnake Crotalus durissus terrificus, on protease-activated receptors,» Toxicon. 2014 mars, vol.79, pp.64-71, 2014.

H. T. Chang and M. C. , «Characterization of a thrombin-like enzyme, grambin, from the venom of Trimeresurus gramineus and its in vivo antithrombotic effect, Toxicon, vol.33, pp.1087-1098, 1995.

E. I. Millers, M. Trabi, P. P. Masci, M. F. Lavin, J. D. Jersey et al., «Crystal Structure of Textilinin-1, a Kunitz-Type Serine Protease Inhibitor From the Venom of the Australian Common Brown Snake, vol.276, pp.3163-3175, 2009.

S. Flight, L. A. Johnson, M. Trabi, and L. P. Masci, «Comparison of Textilinin-1 with Aprotinin as Serine Protease Inhibitors and as Antifibrinolytic Agents,» Pathophysiology of Haemostasis and Thrombosis, vol.34, pp.188-193, 2005.

S. M. Vol, L. A. Johnson, Q. S. Du, R. L. Warner, M. Trabi et al.,

J. D. Lavin, P. P. Jersey, and . Masci, «Textilinin-1, an alternative anti-bleeding agent to aprotinin: Importance of plasmin inhibition in controlling blood loss, British Journal of Haematology, vol.145, pp.207-211, 2009.

X. Z. , «Recombinant textilinin-1 with plasmin inhibition activity, and preparation method and application thereof», Chine Brevet CN102850451 B, 2014.

F. M. Zingali and R. B. , «Bothrojaracin, a Bothrops jararaca snake venom derived (Pro) Thrombin inhibitor, as an antithrobolic molecule, Pathophysiol Haemost Thromb, vol.34, pp.160-163, 2005.

M. Jandrot-perrus, G. M. , and C. Bon, «Bothrojaracin, a new thrombin inhibitor isolated from Bothrops jararaca venom : caracterization and mecanism of thrombin inhibiton, vol.40, pp.10794-10802, 1993.

R. J. Monteiro and R. Q. , «Allosteric changes of thrombin catalytic site induced by interaction of bothrojaracin with anion-binding exosites I and II, Biochem Biophys Res Commun, vol.262, pp.819-822, 1999.

A. Veronique, J. P. Martine, «. Bothrojaracine-:-clonage, S. , E. Cloning et al., , 1997.

, «A better way to prevent blood clots? A drug derived from cobra venom offers an alternative to warfarin, although liver problems temper its benefits, Harv Coeur Lett, vol.15, issue.9, p.3, 2005.

F. Markland, «Fibrolase, an Active Thrombolytic Enzyme in Arterial and Venous Thrombosis Model Systems,» Regardez à l' intérieur Obtenez l' accès, vol.391, pp.427-438, 1996.

C. Toombs, «Alfimeprase: Pharmacology of a Novel Fibrinolytic Metalloproteinase for Thrombolysis,» Haemostsis (fibrinolysis), vol.31, pp.141-147, 2001.

A. D. and A. L. Guan, Archives of Biochemistry and Biophysics, vol.289, issue.%11, pp.197-207, 1991.

S. S. Markland and F. S. , «Fibrolase: trials and tribulations, vol.2, pp.793-808, 2010.
DOI : 10.3390/toxins2040793

URL : http://www.mdpi.com/2072-6651/2/4/793/pdf

S. B. , Pretzer D, «Fibrolase. A fibrinolytic protein from snake venom, » Pharm Biotechnol, vol.5, pp.287-314, 1993.

F. G. ,

F. S. Markland, «Thrombolytic effects of recombinant fibrolase or APSAC in a canine model of carotid artery thrombosis, Circulation, vol.90, pp.2448-2456, 1994.

H. L. Thomas and C. Boone,

. Etats-unis, , 2007.

, Drugs R D, vol.9, pp.185-190, 2008.

M. S. Maity and G. , «Thermal detoxification of the venom from Daboia russelli russelli of Eastern India with restoration of fibrinolytic activity, Toxicon, vol.57, pp.747-754, 2011.

, Viper Venom & Blood Clots,» Herpetological natural history with an emphasis on snakes, 2011.

, /03/russells-viper-venom-blood-clots.html&prev=search, vol.20, p.11

D. P. Gomes and A. , A novel fibrinolytic peptide from the Indian King Cobra (Ophiophagus hannah) venom, Biochem Biophys Res Commun, vol.266, pp.488-491, 1999.

W. A. , Zhang Y, «Trimeresurus stejnegeri snake venom plasminogen activator. Site-directed mutagenesis and molecular modeling, J Biol Chem, vol.272, pp.20531-20537, 1997.

, Marina AA Parry, «The crystal structure of the novel snake venom plasminogen activator TSV-PA: a prototype structure for snake venom serine proteinases, Structure, vol.6, pp.1195-1206, 1998.

. , «Treatment of Acute Cerebral Infarction With Arginine Esterase: A Controlled Study With Heparin, » Cerebrovascular diseases, vol.11, pp.251-256, 2001.

S. P. Girolami and A. , «A novel dysfunctional protein C (Protein C Padua 2) associated with a thrombotic tendency : substitution of Cys for Arg-1 results in a strongly reduced affinity for binding Ca++, » bjh, vol.85, pp.521-527, 1993.

B. N. Lee and T. K. , «Activation of recombinant human protein C, Thromb. Res, vol.82, pp.225-234, 1996.

E. V. , Robert A, «Anticoagulant response to Agkistrodon contortrix venom (AGVtest): a new global test to screen for defects in the anticoagulant protein G pathway, Thromb. Haemost, vol.75, pp.562-566, 1996.

T. P. , H. W. , H. G. , S. Y. , R. B. et al., «Screening for abnormalities of the protein C anticoagulant pathway using the ProC Global assay. Results of a European multicenter evalua, Blood Coagulation and Fibrinolysis, vol.11, pp.447-454, 2000.

V. T. Heilmann and L. , «ProC Global assay in the evaluation of women with history of severe preeclampsia or HELLP syndrome, Clin. Appl. Thromb. Hemost, vol.8, pp.319-324, 2002.

T. Y. Girma and J. P. , «Ristocetin and botrocetin involve two distinct domains of von Willebrand factor for binding to platelet membrane glycoprotein Ib, Thromb Haemost, vol.64, pp.326-332, 1990.

K. D. Veronica and H. Flood, «Limitations of the Ristocetin Cofactor Assay in Measurement of VWF Function, J Thromb Haemost, vol.7, p.111, 2009.

D. Dormann, J. M. Clemetson, A. Navdaev, B. E. Kehrel, and K. J. Clemetson, «Alboaggregin A activates platelets by mechanism involving glycoprotein VI as well as glycoprotein Ib, Blood, vol.97, pp.929-936, 2001.

Y. Usami, M. Suzuki, E. Yoshida, and K. Titani, «Primary structure of AlboaggreginB purified from the venom of Trimeresurus albolabris.,» Biochemical and Biophysical Research Communications, vol.219, pp.727-733, 1996.

M. Peng, W. Lu, and K. E. , «Alboaggregin-B : a new platelet agonist that binds to platelet membrane glycoprotein Ib, Biochemistry, vol.30, pp.11529-11536, 1991.

E. Yoshida, Y. Fujimura, S. Miura, M. Sugimoto, H. Fukui et al., «Alboaggregin-B and botrocetin, two snake venom proteins with highly homologous amino acid sequences but totally distinct functions on Von Willebrand factor binding to platelets, Biochemical and biophysical research communication, vol.191, pp.1386-1392, 1993.

Y. E. , F. Y. , I. Y. , T. , Y. Y. et al., «Impaired highshear-stress-induced platelet aggregation in patients with chronic renal failure undergoing dialysis, » Bjh, vol.89, pp.861-867, 1995.

C. and «. Protéase,

C. H. , Swaim MW, «Characterisation of platelet aggregation induced by PC-3 human prostate adenocarcinoma cells and inhibited by venom peptides, trigramin and rhodostomin, Eur J Cancer, vol.32, pp.715-721, 1996.

F. Navarro and T. , Les toxines d'origine animale posssédant des propriétés analgésiques : mode d'action et application médicale humaine, 2012.

L. A. Calderon, J. C. Sobrinho, K. D. Zaqueo, A. A. Moura, A. N. Grabner et al.,

S. Mazzi, A. Marcussi, C. F. Nomizo, J. P. Fernandes, B. M. Zuliani et al., «Antitumoral Activity of Snake Venom Proteins: New Trends in Cancer Therapy, 2014.

K. B. , Vivek Kumar Vyas, «Therapeutic potential of snake venom in cancer therapy: current perspectives, » Asian Pac J Trop Biomed, vol.3, issue.2, pp.156-162, 2013.

V. K. , Shanbhag, «Applications of snake venoms in treatment of cancer, » Asian Pacific Journal of Tropical Biomedicine, vol.5, pp.275-276, 2015.

V. H. Ebrahim and K. , «Anticancer Activity a of Caspian Cobra ( Naja naja oxiana ) snake Venom in Human Cancer Cell Lines Via Induction of

». Apoptosis and . Iran, J Pharm Res, vol.15, pp.101-112, 2016.

K. S. Jain and D. , Asian Pac J Cancer Préc, vol.13, pp.4855-4860, 2012.

F. J. , Arruda Macêdo JK, «Disintegrins from snake venoms and their applications in cancer research and therapy, Curr Protéine Pept Sci, vol.16, pp.532-548, 2015.

E. P. and -. ,

J. L. Bazaa, «MVL-PLA2, a Snake Venom Phospholipase A2, Inhibits Angiogenesis through an Increase in Microtubule Dynamics and Disorganization of Focal Adhesions, PLoS One, vol.5, p.14, 2010.

C. L. Heloisa and S. Selistre-de-araujo, «Snake Venom Disintegrins and Cell Migration,» Toxines, vol.2, pp.2606-2621, 2010.

J. S. Huang, «A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom, Biochem J, vol.277, pp.351-357, 1991.
DOI : 10.1042/bj2770351

URL : http://europepmc.org/articles/pmc1151241?pdf=render

J. R. Sheu and T. F. , Huang, «Triflavin, an Arg-Gly-Asp-containing peptide, inhibits B16-F10 mouse melanoma cell adhesion to matrix proteins via direct binding to tumor cells, Journal of Biomedical Science, vol.3, pp.359-364, 1996.
DOI : 10.1159/000456940

L. C. Sheu and J. R. Arg, Gly-Asp-containing antiplatelet peptide inhibits cell-substratum adhesion and melanoma cell-induced lung colonization, Jpn J Cancer Res, vol.83, pp.885-893, 1992.
DOI : 10.1111/j.1349-7006.1992.tb01995.x

URL : https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1349-7006.1992.tb01995.x

C. F. Swenson, S. , and «. , Snake Venom Disintegrin with Anti-Angiogenic and Anti-Tumor Activity.,» Pathophysiology of Haemostasis and Thrombosis, vol.34, pp.169-176, 2005.
DOI : 10.1159/000092418

URL : https://www.karger.com/Article/Pdf/92418

S. S. , M. Fs, and C. Tc, «Anti-invasive effect of contortrostatin, a snake venom disintegrin, and TNF-? on malignant glioma cells, » Anticancer research, vol.20, pp.4227-4233, 2000.

C. F. , Swenson S, «Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression, Molecular Cancer Therapeutics, vol.3, pp.499-511, 2004.

S. R. , T. D. Zhou, and Q. , «Contortrostatin, a dimeric disintegrin from Agkistrodon contortrix contortrix, inhibits breast cancer progression, Breast Cancer Res Treat, vol.61, pp.249-60, 2000.
DOI : 10.1023/a:1006457903545

F. C. Stephen-swenson, «Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression, Molecular Cancer Therapeutics, vol.3, pp.499-511, 2004.

S. K. Markland and F. S. , «A novel snake venom disintegrin that inhibits human ovarian cancer dissemination and angiogenesis in an orthotopic nude mouse model, Haemostasis, vol.31, pp.183-91, 2001.

H. C. Minea and R. , «Development of a chimeric recombinant disintegrin as a cost-effective anti-cancer agent with promising translational potential, Toxicon, vol.59, pp.472-486, 2012.

S. S. Minea and R. , «Development of a Novel Recombinant Disintegrin, Contortrostatin, as an Effective Anti-Tumor and Anti-Angiogenic Agent,» Pathophysiology of Haemostasis and Thrombosis, vol.34, pp.177-183, 2005.

A. E. Hailey and S. , «Effect of the disintegrin eristostatin on melanoma-natural killer cell interactions, Toxicon, vol.61, pp.83-93, 2013.

X. Z. and .. M. , Jing Tian, «Eristostatin, an RGD-containing disintegrin, inhibits melanoma cell migration, Proc Amer Assoc Cancer Res, vol.47, 2006.

K. S. , Chung KH, «Inhibitory effect of salmosin, a Korean snake venom-derived disintegrin, on the integrin alphavmediated proliferation of SK-Mel-2 human melanoma cells, J Pharm Pharmacol, vol.55, issue.%111, pp.1577-1582, 2003.

C. K. and -. Kim-doo-sik, «Anti-tumor agent comprising salmosin as an active ingredient». Brevet US-6537551-B2, 28 mars, 2003.

K. S. , Soo In Kim, «Inhibitory effect of the salmosin gene transferred by cationic liposomes on the progression of B16BL6 tumors, Cancer Research, vol.63, p.119, 2003.

P. H. , Yeh CH, «Rhodostomin, a snake venom disintegrin, inhibits angiogenesis elicited by basic fibroblast growth factor and suppresses tumor growth by a selective alpha(v)beta(3) blockade of endothelial cells, Mol Pharmacol, vol.59, pp.1333-1342, 2001.

C. H. Yang and R. S. ,

, Toxicon, vol.46, pp.387-393, 2005.

C. J. , Klein A, «Gene expression in SK-Mel-28 human melanoma cells treated with the snake venom jararhagin, » Toxicon, vol.57, issue.%11, pp.1-8, 2011.

D. S. ,

D. A. Maria, «Antiproliferative effect of the jararhagin toxin on B16F10 murine melanoma, BMC Complement Altern Med, vol.14, p.446, 2014.

F. A. ,

A. E. Mary and . Aranda-souza, «A lectin from Bothrops leucurus snake venom raises cytosolic calcium levels and promotes B16-F10 melanoma necrotic cell death via mitochondrial permeability transition, Toxicon, vol.82, pp.97-103, 2014.

P. N. ,

S. Khunsap, ) from Daboia russelii siamensis venom with anticancer effects, J Venom Res, vol.2, issue.2, pp.42-51, 2011.

I. L. , Rodrigues RS, «Snake venom phospholipases A2: a new class of antitumor agents, Protein Pept Lett, vol.16, pp.894-898, 2009.

, Suchitra Khunsap, «Anticancer properties of phospholipase A 2 from Daboia siamensis venom on human skin melanoma cells, J Venom Anim Toxins Incl Trop Dis, vol.22, p.7, 2016.

A. V. Osipov and Y. N. , Utkin, «Antiproliferative Effects of Snake Venom Phospholipases A 2 and Their Perspectives for Cancer Treatment, Toxins and Drug Discovery, p. Toxins and Drug Discovery, 2015.

J. J. , .. S. , and .. K. , Kessentini-Zouari R, «CC-PLA2-1 and CC-PLA2-2, two Cerastes cerastes venomderived phospholipases A2, inhibit angiogenesis both in vitro and in vivo, Lab Invest, vol.90, pp.510-519, 2010.

L. J. , .. S. , .. K. , .. K. Bazaa, and A. , «MVL-PLA2, a phospholipase A2 from Macrovipera lebetina transmediterranea venom, inhibits tumor cells adhesion and migration, Matrix Biol, vol.28, pp.188-193, 2009.

M. F. , «Antitumor action of crotalase, a defibrinogenating snake venom enzyme, Semin Thromb Hemost, vol.12, pp.284-290, 1986.

D. F. Rj-da, «. Silva, . Effect, . Snake, ». J. Venoms et al., Anim. Toxines, vol.2, p.12, 1996.

A. ,. Chmielewska, «Effect of defibrination with batroxobin on growth and metastasis of JW sarcoma in mice, European Journal of Cancer, vol.16, pp.919-923, 1965.

A. N. Sanjesh and . Kumar, «A NOVEL BIOCHEMICAL AND PHARMACOLOGICALAGENT: L-AMINO ACID OXIDASE WITH CORRELATION TO CANCER MANAGEMENT: AN OVERVIEW, vol.4, pp.33-38, 2014.

L. B. , Ahn MY, «Characterization and cytotoxicity of L-amino acid oxidase from the venom of king cobra (Ophiophagus hannah, Int J Biochem Cell Biol, vol.29, pp.911-919, 1997.

S. Ma, P. Pb, F. Cl, L. Antonelli, and S. Rg, «Crotalus durissus terrificus venom as a source of antitumoral agents, J. Venom. Anim. Toxines incl. Trop. Dis, vol.16, issue.3, p.13, 2010.

L. A. Juan-carlos and . Vidal, «Use of compositions based on crotoxine, for the manufacture of a medicament for the treatment of carcinomas», vol.10, 1987.

, Rong Han, «Crotoxin induces apoptosis and autophagy in human lung carcinoma cells in vitro via activation of the p38MAPK signaling pathway, Acta Pharmacologica Sinica, vol.35, pp.1323-1332, 2014.

B. D. ,

J. E. Cura, NSC624244) in patients with advanced cancer, «Phase I and pharmacokinetics study of crotoxin (cytotoxic PLA, vol.8, pp.1033-1044, 2002.

K. I. , .. R. , .. V. Kerkis, and A. ,

, FASEB J, vol.18, pp.1407-1409, 2004.

I. K. ,

B. D. , Tetsuo Yamane, «Use of Crotamine and Composition». Sao Paulo Brevet EP 1866332 B1, pp.17-26

.. T. , Rádis-Baptista G, «Insights into the uptake mechanism of NrTP, a cell-penetrating peptide preferentially targeting the nucleolus of tumour cells, Chem Biol Drug Des, vol.79, pp.907-915, 2012.

P. L. and -. J. Nicole-caroline-mambelli, Crotamine derived fusion short-peptides and their effect on melanoma and breast cancer cells cultured in vitro, » Drug Sensitivity and Resistance: Improving Cancer Therapy, vol.21, p.14, 2015.

S. Innovation, press-releases/spotlight-innovation-subsidiary-celtic-biotech-retainsexclusive-license-for-use-of-crotamine-as-cancer-imaging-gene-therapytechnology-from-instituto-bu, 2015.

B. D. , Payel Bhattacharjee, «Factor V Activator from Daboia russelli russelli Venom Destabilizes ?-Amyloid Aggregate, the Hallmark of Alzheimer Disease, J Biol Chem, vol.288, pp.30559-30570, 2013.

. , Ian Smith, «N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme-1 and Neprilysin, n° %122413, vol.6, pp.2-03

N. R. Sanjaya and . Kuruppu, «N-terminal domain of Bothrops asper Myotoxin II Enhances the Activity of Endothelin Converting Enzyme and Neprilysin, The FASEB Journal, vol.30, p.11, 2016.

A. Harvey and B. Robertson, «Dendrotoxins: Structure-Activity Relationships and Effects on Potassium Ion Channels, vol.11, pp.3065-3072, 2004.

X. Z. , Amrita Roy, «Structural and Functional Characterization of a Novel Homodimeric Three-finger Neurotoxin from the Venom of Ophiophagus hannah, The Journal of Biological Chemistry, vol.285, issue.%111, pp.8302-8315, 2010.

M. J. Kostiza and T. , «Nerve growth factors from snake venoms: chemical properties, mode of action and biological significance, Toxicon, vol.34, pp.787-806, 1996.

R. Pf, «Alpha-cobratoxin as a possible therapy for multiple sclerosis: a review of the literature leading to its development for this application, Crit Rev Immunol, vol.27, pp.291-302, 2007.

R. P. , Mohamed A, «Amelioration of acute and relapsing stages of the experimental allergic encephalomyelitis by cobra toxins, Biomed Sci Instrum, vol.42, pp.399-404, 2006.

Y. L. , .. D. , .. W. , and .. L. , Chengyong Shen, «Antibodies against low-density lipoprotein receptor-related protein 4 induce myasthenia gravis, J Clin Invest, vol.123, pp.5190-5202, 2013.

C. Ns, «Contribution of a snake venom toxin to myasthenia gravis: the discovery of alpha-bungarotoxin in Taiwan, J Hist Neurosci, vol.14, pp.138-148, 2005.

N. Cerdan, «Prédominance des fibres musculaires lentes chez le chien CNM : Analyse en situation de régénération provoquée, pp.27-32, 2003.

R. Yiou, «Traitement de l'incontinence urinaire par injection des cellules précurseurs musculaires : analyse des résultats préliminaires, John Libbey (Eurotext), vol.15, p.13, 2009.

S. A. Lefaucheur and J. P. , «The cellular events of injured muscle regeneration depend on the nature of the injury, Neuromuscul Disord, vol.5, pp.501-509, 1995.

, «Beneficial effect of crotamine in the treatment of myasthenic rats, Muscle Nerve, vol.47, pp.591-593, 2013.

.. A. Galanopoulo, «Un venin de serpent pour traiter l'épilepsie et la schizophrénie, 2015.

P. S. Gawade and S. P. , «Pharmaco-photodynamics of photo-oxidised Russell's Viper venom product generated using UV radiation in the presence of methylene blue, » Indian journal of pharmaceutical education, vol.41, issue.2, pp.121-128, 2007.

R. Cm and G. Sp, «Evaluation of the effects of photooxidized Echis carinatus venom on learning, memory and stress, J. Venom. Anim. Toxines incl. Trop. Dis, vol.12, issue.%14, 2006.

S. P. Gawade, «Pharmaco-photodynamics of photo-oxidised snake venom products: Comparative evaluation, » RGUHS Journal of Pharmaceutical Sciences, vol.1, pp.180-185, 2011.

A. , Naftali Primor, «Analgesic from snake venom», Brevet US, vol.1, p.14

, Juillet, 1999.

. , SFETD), «La Douleur, définition.,» Société Française d'Etude et Traitement de la Douleur (SFETD), 2016.

E. D. Lingueglia, . Ionique, ». Douleur, and . Ipmc, Institut de Pharmacologie Moléculaire et Cellulaire, Available: Tous les articles sur

M. Cr and S. S. , «Analgesic substances derived from natural products (natureceuticals), Life Sei, vol.78, pp.476-484, 2005.

C. A. N.-r and . Cj-bohlen, «A heteromeric Texas coral snake toxin targets acid-sensing ion channels to produce pain, Nature, vol.479, pp.410-414, 2011.

F. R. ,

S. Marra, «Non-acidic activation of pain-related Acid-Sensing Ion Channel 3 by lipids, EMBO J, vol.15, issue.4, pp.414-428, 2016.

, «The dark side and the bright one of Black Mamba venom

L. Ronat, M. Réalisateur, . Noirs, and . Mambalgines, France: CNRS Images, 2013.

. , Diochot S, «Black mamba venom peptides target acid-sensing ion channels to abolish pain, Nature, vol.490, pp.552-555, 2012.

S. M. ,

G. Mourier, «Mambalgin-1 Pain-relieving Peptide, Stepwise Solid-phase Synthesis, Crystal Structure, and Functional Domain for Acid-sensing Ion Channel 1a

, J Biol Chem, vol.291, pp.2616-2629, 2016.

, ANR, «Exploration pharmacologique du rôle des canaux ASIC dans la douleur.,» ANR (Agence Nationale de la Recherche, 2016.

S. Teboule, «Le venin du mamba noir: meilleur antalgique que la morphine?,» 04 10 2012

J. Chaput, «Antidouleur : le venin du black mamba, analgésique du futur ?,» Futura Sciences, 2012.

A. A. ,

S. Diochot, «Analgesic effects of mambalgin peptide inhibitors of acid-sensing ion channels in inflammatory and neuropathic pain, Douleur, vol.157, pp.552-559, 2016.

A. L. Harvey, . Discovery, and . Toxicon, , vol.92, pp.193-200, 2014.

X. Pu, P. Wong, and P. Gopalakrishnakone, «A novel analgesic toxin (hannalgesin) from the venom of king cobra (Ophiophagus hannah), Toxicon, vol.33, issue.%111, pp.1425-1431, 1995.

U. N. , Singapour, «Therapeutic molecules derived from snake venom», US Brevet US6613745, vol.1, 2003.

M. L. , Theralpha), «Analgesic Composition for Transbuccal Administration». US Brevet US20120183580 A1, 2012.

J. Badina, «Un venin de cobra contre la douleur,» Pharmaceutiques, l'information de réfernce du secteur pharmaceutique, 0909.

Y. Cc, «Cobrotoxin: structure and function, J Nat Toxines, vol.8, pp.221-233, 1999.

K. T. and .. Y. , Hsieh HC, «Clonage, surexpression et la caractérisation des cobrotoxin, Biochem Biophys Res Commun, vol.320, pp.1374-1381, 2004.

C. Y. , Chang LS, «A novel neurotoxin, cobrotoxin b, from Naja naja atra (Taiwan cobra) venom: purification, characterization, and gene organization, J Biochem, vol.122, pp.1252-1259, 1997.

F. J. and .. J. , Li F, «Delivery of 125I-cobrotoxin after intranasal administration to the brain: A microdialysis study in freely moving rats, Int. J. Pharm, vol.328, pp.161-167, 2007.

Z. H. Chen and Z. X. , «A longform ?neurotoxin from cobra venom produces potent opioid-independent analgesia, Acta Pharmacol Sin, vol.27, pp.402-408, 2006.

C. S. , Xu JM, «Cobrotoxin-containing analgesic compound to treat chronic moderate to severe cancer pain: results from a randomized, double-blind, cross-over study and from an open-label study, Oncol Rep, vol.16, pp.1077-1084, 2006.

L. Yanli, Q. Zhenghong, and R. Zou, «Use of cobrotoxin for manufacturing a medicament for the treatment of arthritis, Chine) Brevet CN101648000A, CN101648000B, WO 2011026362 A1, 2011.

J. Shen, Y. Xie, M. Sun, R. Han, Z. Qing et al., He, «Antitumor activity of cobrotoxin in human lung adenocarcinoma A549 cells and following transplantation nude mice, Oncology Letters, pp.1961-1965, 2014.

T. T. ,

Y. Bourne, «Crystal structure of a Cbtx-AChBP complex reveals essential interactions between snake alpha-neurotoxins and nicotinic receptors, EMBO J, vol.24, pp.1512-1534, 2005.

Z. Y. , Zhang L, «Alpha-cobratoxin inhibits T-type calcium currents through muscarinic M4 receptor and G o-protein ?? subunits-dependent protein kinase A pathway in dorsal root ganglion neurons, » Neuropharmacology, vol.62, pp.1062-1072, 2012.

Z. X. , Cheng BC, «Cobratoxin inhibits pain-evoked discharge of neurons in thalamic parafascicular nucleus in rats: involvement of cholinergic and serotonergic systems, Toxicon, vol.54, pp.224-256, 2009.

H. R. Zhang and H. L. , » Neurosci Bull, vol.22, pp.267-273, 2006.

M. B. Giorgi, «. R. Giorgi, Y. Bernardi, and . Cury, L'effet analgésique évoqué par faible poids moléculaire, » Toxicon, vol.31, pp.1257-1265, 1993.

P. G. Konno, K. , and «. , South American rattlesnake Crotalus durissus terrificus, vol.29, pp.1293-1304, 2008.

P. G. , G. R. , and C. , «delta-opioid receptors and nitric oxide mediate the analgesic effect of Crotalus durissus terrificus snake venom, Eur J Pharmacol, vol.391, pp.55-62, 2000.

P. G. , C. Ac, and C. , «Activation of peripheral ATP-sensitive K+ channels mediates the antinociceptive effect of Crotalus durissus terrificus snake venom, Eur J Pharmacol, vol.469, pp.57-64, 2003.

P. G. and C. , «Peripheral neuronal nitric oxide synthase activity mediates the antinociceptive effect of Crotalus durissus terrificus snake venom, a delta-and kappa-opioid receptor agonist, Life Sci, vol.75, pp.559-573, 2004.

H. F. ,

P. Brigatte, «Tolerance to the antinociceptive effect of Crotalus durissus terrificus snake venom in mice is mediated by pharmacodynamic mechanisms, Toxicon, vol.39, pp.1399-1410, 2001.

J. H. , Erica Cristina Bueno do Prado Guirro, «Clinical, behavioral and antinociceptive effects of crotalphine in horses, Cienc. Rural, vol.46, issue.4, p.14, 2016.

K. K. ,

V. P. Gutierrez, «Crotalphine induces potent antinociception in neuropathic pain by acting at peripheral opioid receptors, Eur J Pharmacol, vol.594, pp.84-92, 2008.

Z. V. Gutierrez and V. P. , «The peripheral L-arginine-nitric oxide-cyclic GMP pathway and ATP-sensitive K? channels are involved in the antinociceptive effect of crotalphine on neuropathic pain in rats, Behav Pharmacol, vol.23, issue.%11, pp.14-24, 2012.

Z. V. Machado and F. C. , «Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine, Br J Pharmacol, vol.171, pp.961-972, 2014.

E. Bressan, F. Touska, I. Vetter, K. Kistner, T. I. Kichko et al., , 2016.

F. A. and .. M. -r, Zambelli VO 1, «Peripheral sensitization increases opioid receptor expression and activation by crotalphine in rats, PLoS One, vol.9, p.13, 2014.

S. Sampaio, S. Hyslop, M. Fontes, J. Prado-franceschi, V. Zambelli et al., TOXICON, vol.55, pp.1045-1060, 2010.

J. E. , Cura, «Phase I and Pharmacokinetics Study of Crotoxin (Cytotoxic PLA 2 , NSC-624244) in Patients with Advanced Cancer, » Clin cancer resarch, vol.8, pp.1033-1041, 2002.

H. R. ,

H. L. Zhang, acetylcholine-independent analgesic actions of crotoxin isolated from crotalus durissus terrificus venom, Toxicon, vol.48, pp.175-182, 2006.

W. D. , Zhu Q, «Inhibitory effect of crotoxin on the pain-evoked discharge of neurons in thalamic parafascicular nucleus in rats, Toxicon, vol.51, issue.%11, pp.102-111, 2008.

R. L. ,

C. Francisco-de-sousa-nogueira-neto, «The analgesic effect of crotoxin on neuropathic pain is mediated by central muscarinic receptors and 5-lipoxygenasederived mediators, Pharmacology Biochemistry and Behavior, vol.91, pp.252-260, 2008.

«. Wikipedia,

J. Chippaux and M. Goyffon,

A. Guyard,

A. , «La denture des serpents, 2008.

J. L. Sarray, «Snake venoms C-type lectins and their receptors on platelets and cancerous cells, Archives. Institu. Pasteur Tunis, vol.85, pp.69-80, 2008.

S. M. , Moore GW, «The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinized patients with lupus anticoagulants, Blood

M. M. , Laraba-Djebari F, «Afaâcytin, an alpha betafibrinogenase from Cerastes cerastes (horned viper) venom, activates purified factor X and induces serotonin release from human blood platelets, Eur J Biochem, vol.233, pp.756-765, 1995.

. Valium, , vol.07, p.6, 2013.

Z. H. Chen and Z. X. , «A long-form alphaneurotoxin from cobra venom produces potent opioid-independent analgesia, Acta Pharmacol Sin, vol.27, pp.402-408, 2006.

. , Toxines à 3 doigts et mécanismes d'actions, vol.1

. , Famille de désintégrines et toxines associées, vol.2

. , Différences entre protéines naturelles et de synthèses, Tableau, vol.3

. , Effets physiologiques des peptides natriurétiques, vol.4

. , Effets des protéines sur les différentes cibles de l'hémostase, vol.5

. , Diagnostic d'une mutation du Facteur V, Tableau, vol.6

. , Classes des inhibiteurs de l'activation plaquettaire, vol.7

S. Sarray, Effets des extraits du venin ophidien sur les cellules cancéreuses, vol.8, 2013.

, Comparaison de l'efficacité de l'Hannalgésine avec la Morphine et un témoin, Tableau, vol.9, p.392